Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Patients with diabetes treated with insulin often gain weight, which may deter patients from
adhering to insulin treatment. Detemir is one type of long acting insulin approved by the
Food and Drug Administration for use in people with diabetes. It is similar to other long
acting insulins (Neutral Protein Hagedorn [NPH], glargine) except that it has been associated
with less weight gain compared to other types of insulin. The reasons for this are still
unclear. One possibility is that detemir insulin acts differently than do other insulins in
affecting how diabetic patients eat meals. The purpose of this study is to determine whether
appetite and calories eaten during a meal are affected by the type of insulin used to treat
diabetes. This is a pilot study which means we are gathering preliminary information to
determine if a larger study can be done.